A novel diagnostic marker, p28GANK distinguishes hepatocellular carcinoma from potential mimics

Journal of Cancer Research and Clinical Oncology

Volumn 130, Issue 9, 2004, Pages 514-520

  Fu, Xiaoyong ^a   Tan, Lu ^a   Liu, Shuqin ^a   Li, Honghai ^a   Chen, Lei ^a   Qin, Jianmin ^a   Wu, Mengchao ^a   Wang, Hongyang ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Immunohistochemistry; Liver; p28GANK

Indexed keywords

ALPHA FETOPROTEIN; BIOLOGICAL MARKER; CYTOKERATIN 18; GANK P28 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BILE DUCT CARCINOMA; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABORATORY DIAGNOSIS; LIVER CELL CARCINOMA; PRIORITY JOURNAL;

EID: 4344698829     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-004-0562-y     Document Type: Article

References (30)

1. Baumeister W, Walz J, Zuhl F, Seemuller E (1998) The proteasome: paradigm of a self-compartmentalizing protease. Cell 92:367-380
2. Chen CJ, Yu MW, Liaw YF (1997) Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol 12:S294-308
3. Christensen WN, Boitnott JK, Kuhajda FP (1989) Immunoperoxidase staining as a diagnostic aid for hepatocellular carcinoma. Mod Pathol 2:8-12
4. Chu PG, Ishizawa S, Wu E, Weiss LM (2002) Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein. Am J Surg Pathol 26:978-988
5. D'Errico A, Baccarini P, Fiorentino M, et al (1996) Histogenesis of primary liver carcinomas: strengths and weaknesses of cytokeratin profile and albumin mRNA detection. Hum Pathol 27:599-604
6. Edmundson HA, Steiner PE (1954) Primary carcinoma of the liver. A study of 100 cases among 48,900 necropsies. Cancer 7:462-503
7. Fu XY, Wang HY, Tan L, et al (2002) Overexpression of p28/gankyrin in human hepatocellular carcinoma and its clinical significance. World J Gastroenterol 8:638-643
8. Ganjei P, Nadji M, Albores-Saavedra J, et al (1988) Histologic markers in primary and metastatic tumors of the liver. Cancer 62:1994-1998
9. Higashitsuji H, Itoh K, Nagao T, et al (2000) Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas. Nature Med 6:96-99
10. Hori T, Kato S, Saeki M, et al (1998) cDNA cloning and functional analysis of p28(Nas6p) and p40.5(Nas7p), two novel regulatory subunits of the 26S proteasome. Gene 216:113-122
11. Hurlimann J, Gardiol D (1991) Immunohistochemistry in the differential diagnosis of liver carcinomas. Am J Surg Pathol 15:280-288
12. Kumagai I, Masuda T, Sato S, Ishikawa K (2001) Immunoreactivity to monoclonal antibody, Hep Par 1, in human hepatocellular carcinomas according to histopathological grade and histological pattern. Hepatol Res 20:312-319
13. Lau SK, Prakash S, Geller SA, Alsabeh R (2002) Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma. Hum Pathol 33:1175-1181
14. Leong AS, Sormunen RT, Tsui WM, Liew CT (1998) Hep Par 1 and selected antibodies in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma, combined tumours and metastatic carcinoma. Histopathology 33:318-324
15. Li J, Tsai MD (2002) Novel insights into the INK4-CDK4/6-Rb pathway: counter action of gankyrin against INK4 proteins regulates the CDK4-mediated phosphorylation of Rb. Biochemistry 41:3977-3983
16. Ma CK, Zarbo RJ, Frierson HF Jr, et al (1993) Comparative immunohistochemical study of primary and metastatic carcinomas of the liver. Am J Clin Pathol 99:551-557
17. Maeda T, Kajiyama K, Adachi E, et al (1996) The expression of cytokeratins 7, 19, and 20 in primary and metastatic carcinomas of the liver. Mod Pathol 9:901-909
18. Minervini MI, Demetris AJ, Lee RG, et al (1997) Utilization of hepatocyte-specific antibody in the immunocytochemical evaluation of liver tumors. Mod Pathol 10:686-692
19. Morrison C, Marsh W Jr, Frankel WL (2002) A comparison of CD10 to pCEA, MOC-31, and hepatocyte for the distinction of malignant tumors in the liver. Mod Pathol 15:1279-1287
20. Ogawa A, Kanda T, Sugihara S et al (1996) Correlation between serum level of, and tissue positivity for, alpha-fetoprotein in hepatocellular carcinoma. J Med 27:33-40
21. Park TJ, Kim HS, Byun KH, Jang JJ, Lee YS, Lim IK (2001) Sequential changes in hepatocarcinogenesis induced by diethylnitrosamine plus thioacetamide in Fischer 344 rats: induction of gankyrin expression in liver fibrosis, pRB degradation in cirrhosis, and methylation of p16(INK4A) exon 1 in hepatocellular carcinoma. Mol Carcinog 30:138-150
22. Qin JM, Fu XY, Li SJ, et al (2003) Gene and protein expressions of p28 in rat with liver regeneration. World J Gastroenterol 9:2523-2527
23. Rishi M, Kovatich A, Ehya H (1994) Utility of polyclonal and monoclonal antibodies against carcinoembryonic antigen in hepatic fine-needle aspirates. Diagn Cytopathol 11:358-361
24. Sato K, Tanaka M, Kusaba T, et al (1998) Immunohistochemical demonstration of alpha-fetoprotein in small hepatocellular carcinoma. Oncol Rep 5:355-358
25. Sithinamsuwan P, Piratvisuth T, Tanomkiat W, et al (2000) Review of 336 patients with hepatocellular carcinoma at Songklanagarind Hospital. World J Gastroenterol 6:339-343
26. Sylla A, Diallo MS, Castegnaro J, Wild CP (1999) Interactions between hepatitis B virus infection and exposure to aflatoxins in the development of hepatocellular carcinoma: a molecular epidemiological approach. Mutat Res 428:187-196
27. Tang ZY (2000) Hepatocellular carcinoma. J Gastroenterol Hepatol 15 [Suppl]:G1-7
28. Tsuji M, Kashihara T, Terada N, Mori H (1999) An immunohistochemical study of hepatic atypical adenomatous hyperplasia, hepatocellular carcinoma, and cholangiocarcinoma with alpha-fetoprotein, carcinoembryonic antigen, CA19-9, epithelial membrane antigen, and cytokeratins 18 and 19. Pathol Int 49:310-317
29. Wee A, Nilsson B (1997) pCEA canalicular immunostaining in fine needle aspiration biopsy diagnosis of hepatocellular carcinoma. Acta Cytol 41:1147-1155
30. Yao JL (1996) Perinatal transmission of hepatitis B virus infection and vaccination in China. Gut 38 [Suppl 2]:S37-38